In its quest to become a larger player in the global medical device market, Samsung Electronics Co. Ltd. creates a new brand to represent its collaboration with Korea-based diagnostic ultrasound equipment maker Medison Co.: Samsung Medison Co. Ltd.

Samsung Electronics Co. Ltd. (KSE:005930.KS) launched a new corporate identity for medical products created through its collaboration with Korea based ultrasound equipment maker Medison Co.

The combined group, Samsung Medison, has a goal of becoming one of the world's top 4 diagnostic ultrasound firms and, by 2020, aims to have 10,000 employees, according to the company.

The Irvine, Calif.-based company reported that an independent study demonstrated that noninvasive Masimo carboxyhemoglobin (SpCO) measurements provide an "effective means for screening at-risk populations for CO poisoning" with "acceptable bias and precision" compared to invasive blood gas analysis. The results were published in the April issue of Annals of Emergency Medicine.

Rhythmia Medical secures nearly $2.7 million in new equity funding to assist development of its heart-mapping device.

Rhythmia Medical Inc. raised nearly $2.7 million in a third-round equity sale to a group of 14 investors, according to new securities documents.

Burlington, Mass.-based Rhythmia, founded in 2004 by two Israeli entrepreneurs, is developing medical devices able to quickly map the electrical activity of the heart and pinpoint catheter ablation procedures.